An investigational drug appears to cut the risk of severe asthma attacks in half for patients who have difficulty controlling the disorder with standard medications, according to results from two multicenter clinical trials headed by Mario Castro, MD, the Alan A. and Edith L. Wolff Professor of Pulmonary and Critical Care Medicine at the School of Medicine.
Adding vitamin D to asthma treatment to improve breathing only appears to benefit patients who achieve sufficient levels of the supplement in the blood. Overall, the ability to control asthma did not differ between a study group that received vitamin D supplements and a group that received placebo. Mario Castro, MD, (left) led the study.
Mario Castro, MD, has been named the Alan A. and Edith L. Wolff Professor of Pulmonary and Critical Care Medicine at the School of Medicine. He is a noted authority on asthma and other respiratory diseases.
Mario Castro, MD, and Angela Brown, MD, will lead a new office in the Department of Medicine that supports faculty members’ career development. The new program will feature workshops and seminars to promote faculty career development in the areas of research, clinical care, education and leadership.
A drug commonly used for the treatment of chronic obstructive pulmonary disease (COPD) successfully treats adults whose asthma is not well controlled on low doses of inhaled corticosteroids, says a new study.